English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Vimbai Chikomo
| Apr 6, 2016
Obamacare is failing to discipline Florida insurers for discriminating against hepatitis C patients, according to expert
Amanda Rupp
| Apr 5, 2016
Merck to disclose new discoveries from chronic hepatitis C virus studies
Amanda Rupp
| Apr 5, 2016
EMA accepts rheumatoid arthritis treatment from Pfizer
Amanda Rupp
| Apr 5, 2016
Health professionals determined to provide alternatives to opioid treatments
Amanda Rupp
| Apr 5, 2016
White House meeting discusses HIV stigma, LGBT health concerns
Amanda Rupp
| Apr 5, 2016
Eisai withdraws new ALS drug application
Vimbai Chikomo
| Apr 5, 2016
Oregon set to construct new Obamacare exchange after failed attempt costs $305 million
Amanda Rupp
| Apr 4, 2016
Study suggests bypass surgery could lengthen lives of patients with heart failure
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
« First
«
…
223
224
225
226
227
228
229
…
»
Last »